Drugs / Dapaconazole
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT02824926 | Jul → Dec 2014 | tinea pedis | Gilberto De Nucci | Completed | No outcome recorded |
| Phase 2 | NCT03359070 | Jan → Dec 2014 | dermatophytosis of groin and perianal area | Galeno Desenvolvimento de Pesquisas Clínicas | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT03320486 | Nov 2017 → Aug 2019 | tinea pedis | Biolab Sanus Farmaceutica | Completed | No outcome recorded |
| Phase 3 | NCT02606383 | Jun → Dec 2016 | tinea pedis | Biolab Sanus Farmaceutica | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dapaconazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02606383 ↗ |
| Known as | Dapaconazol | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297506 ↗ |
| Modality | Small molecule | — CHEMBL4297506 ↗ |
| Route | Topical | “Dapaconazole 2% Cream Topical” NCT02606383 ↗ |